LongeVC’s Post

Bio€quity Europe is off to an outstanding start with the convergence of life sciences companies, investors, local and EU government, and those of us who support our clients in further support of advancing global public health! Our session today was moderated by Selina Koch, PhD , BioCentury Inc. and included Jennifer McMahon, Seroba, Edward Kliphuis, Sofinnova Partners, John W Cassidy, Kindred Capital VC, Florent Gros, Earlybird Venture Capital. I was thrilled to join such an outstanding group of investors to discuss the opportunities for AI to influence drug discovery, research and development! #BioEquityEurope

Congrats to Vivalyx, an innovative Organ Vitality Tech startup based in Aachen, on successfully closing an oversubscribed seed funding round, raising above EUR 5 million. Investors include leading European Life Science and Deeptech venture capital firms such as Brightlands Venture Partners, TechVision Fonds, Arve Capital, the American Deeptech VC Goose Capital, and notable private angel investors.   The funding enables Vivalyx to finance the clinical study required for regulatory approval. This crucial step paves the way for the launch of the innovative organ preservation solution, which has the potential to extend the lifespan of donor organs and enhance their vitality. Vivalyx technology aims to significantly increase the number of organs available for transplantation, thus saving and improving the lives of patients worldwide – at significantly lower costs, considerably reduced complexity, and streamlined processes.   Thumbs up also to the international Orrick team including Ilona Schütz, David Hamala, Sven Greulich, Benedikt Migdal and further colleagues.   Orrick, Herrington & Sutcliffe LLP #medtech #lifesciences #organdonation #venturecapital #founders #innovation #TeamOrrick

This video is just a peek into the extraordinary hard work that has been put in over the past few months from everyone involved - especially by the 11 companies who completed the Founders at the University of Cambridge Start 1.0 Accelerator Programme. We're so proud of this initiative, and we can't wait to see where it takes our founders, and us, next. #Innovation #Founders #UniversityOfCambridge #Investors #DemoDay

Investing for impact in braintech. 🧠 by August Solliv, Author of Impact Supporters. 👇 Why it matters.👇 Braintech is emerging as a crucial impact area due to an aging population and a surge in chronic and neurological diseases. Anne-Sophie Saint-Martin of Newfund highlights that braintech startups in Europe rival those in the USA in quality but face monetization challenges. FDA approval remains a significant hurdle, yet partnerships, like Newfund’s with FondaMental Foundation, help mitigate these risks. The largest trend in braintech is techbio, which accelerates drug discovery and patient care. Understanding these dynamics can guide VCs and LPs in supporting impactful braintech ventures, driving advancements in diagnosing and treating neurological diseases. Read the interview with Anne-Sophie Saint-Martin from Newfund on EUVC Insights! 🔽 https://buff.ly/3XPYaGE #venturecapital #startupfunding #Europe #EUVCInsights

Move for mental health: let’s invest!

The time has come for the first Bi-weekly update from the Aniverse in 2024! The last two weeks were permeated with secretive happenings, so I will summarize it without disclosing the details (those will go out in the following few weeks): 1) VC Investment Four years after starting a company, during the most brutal fundraising environment ever, after investments from EIT Climate-KIC RIS and 70 angel investors, we realized our first VC investment. More about our lucky partners soon! (joke, the luck is mutual) 2) New HQ We signed the contract for the new, 3x bigger HQ that will unify offices, production, lab, fulfillment, and warehouse. We are moving in this month and will share more soon! 3) Clinical study - results We received the raw data from the participants of our first clinical trial. Our bioinformaticians interpreted the results, and I could just say that they are better than expected, confirming the power of bioactive compounds for gut health. These are only the first 28 samples (the study altogether has 150 ppl through 3 arms) - the official results are coming out soon! 4) Scientific Advisory Board We formed our Scientific Advisory Board of four extraordinary international scientists. We will onboard two more in the following two weeks and disclose all of them at once. 5) New team members We have three more scientists in our core team. I'll share each in the following posts (starting with this one). The following two weeks are reserved for the magic of shaping the future: - Marta, Manuela, Iva, and I will be presenting Ani Biome at CES in Las Vegas (Dragan & Bojan, thanks for this opportunity one more time; see you soon!), after which we will go together to our US HQ in SF - Nika will be presenting Ani on a few longevity panels at the World Economic Forum in Davos Looking forward to everything 2024 will bring! 🦄 💫 👅 #longevity #biotech #startup #venturecapital #investment #machinelearning #scienceandtechnology #mentalhealth #guthealth

Are you a #femtech company, founder, or enthusiast who is interested in learning more about building and commercializing femtech products? If so, you won't want to miss this Emerging Femtech event on September 1st at 4:00 pm EST (virtual and free to attend)! Emerging Femtech is a virtual event series supported by the Harvard GSAS Business Club, Mignone Center for Career Success, and MIT Sandbox Innovation Fund Program with a goal of highlighting and fostering dialogue on the vital role of innovation in advancing #womenshealth. Huge shoutout to Kimia Sorouri, MD, MPH, Heer Joisher and Sharan Rai, PhD for their work in putting this event series together! In this virtual event, I'll be exploring the foundations of femtech, how to build and commercialize femtech products, legal and regulatory frameworks that founders must navigate, and the need for collaboration between femtech founders and clinicians/scientists. I'm so excited and honored to be part of this event and hope you'll join us for this amazing series! Registration link in the comments. #healthinnovation #startuplaw #startupgrowth #healthcareinnovation FemInnovation

Verge Healthtech Fund is gearing up for three dynamic panel discussions at DTX ASIA 2023 tomorrow! First, head to the "Keynote Panel Discussion: Why Bring DTx to Asia?" on the morning of Nov 29. Listen to our Managing Partner, Scarlett Chen 陈思佳, and her co-panelists delve into success factors for digital therapeutics and its adoption in Asia, accessibility in low-resource settings, and integration with other health tools. 🌏 Then in the afternoon, join our co-founder and Managing Partner, Joseph Mocanu, for the “A One Stop Shop on What A Digital Health Investor Seeks in a DTx Company" panel, where he and his co-panelists will explore the landscape of DTx investments, how they balance profitability with impact, and how to foster successful collaborations between DTx companies and investors. 🤝 The following morning on Nov 30, catch our co-founder and General Partner, Ed Deng, appearing in the “Panel Discussion: Identifying the Gaps in DTx: What is the Industry Missing?” Ed will be representing his startup, Health2Sync 智抗糖, a comprehensive health management platform helping chronic disease patients improve their health conditions with personalized digital therapeutics.🩸 Whether you're a startup on a mission to solve global health challenges through digital therapeutics, or a fellow investor of impactful healthtech startups, we invite you to connect. We’ll be at the summit until Nov 30. 👥 #dtx #dtxasia #digitalhealth #digitaltherapeutics

Here's to the Adelaide founders that moved the needle. Here's to their vision and the courage to pursue it. Here's to their late nights and weekends, month after month, year after year. Here's to their family, friends, and those who support them. Again. And again. And again. Here's to throwing old versions in the bin and re-building. Here's to pushing through 100 NOs to get to a YES! Here's to proving themselves right. Here's to solving problems others can't see. Here's to creating magnificent solutions to hard problems loved by fans. Here's to creating 100% of our net new jobs. Here's to raising tax revenue from abroad so local service can be better. Here's to Adelaide's heroes - founders. Leading to Adelaide being mentioned for the first time in the Startup Genome 2024 Global Startup Ecosystem Report https://lnkd.in/g_f5g-qR